+1 (704) 266-3234

Global Anti-PD-1 MAb Sales Market Report 2021

Published on: Jun 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 137

The global Anti-PD-1 MAb market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-PD-1 MAb market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
40mg
100mg
200mg
Others

Segment by Application
Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other

The Anti-PD-1 MAb market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-PD-1 MAb market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Bristol Myers Squibb
Merck
Junshi Pharma
Innovent Biologics Inc
Hengrui Medicine
Beijing Beigene

1 Anti-PD-1 MAb Market Overview
1.1 Anti-PD-1 MAb Product Scope
1.2 Anti-PD-1 MAb Segment by Type
1.2.1 Global Anti-PD-1 MAb Sales by Type (2016 & 2021 & 2027)
1.2.2 40mg
1.2.3 100mg
1.2.4 200mg
1.2.5 Others
1.3 Anti-PD-1 MAb Segment by Application
1.3.1 Global Anti-PD-1 MAb Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Melanoma Patients
1.3.3 Lung Cancer Patients
1.3.4 Lymphoma Patients
1.3.5 Other
1.4 Anti-PD-1 MAb Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-PD-1 MAb Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-PD-1 MAb Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-PD-1 MAb Price Trends (2016-2027)

2 Anti-PD-1 MAb Estimates and Forecasts by Region
2.1 Global Anti-PD-1 MAb Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-PD-1 MAb Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-PD-1 MAb Revenue Market Share by Region (2016-2021)
2.3 Global Anti-PD-1 MAb Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-PD-1 MAb Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-PD-1 MAb Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-PD-1 MAb Estimates and Projections (2016-2027)
2.4.2 Europe Anti-PD-1 MAb Estimates and Projections (2016-2027)
2.4.3 China Anti-PD-1 MAb Estimates and Projections (2016-2027)
2.4.4 Japan Anti-PD-1 MAb Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-PD-1 MAb Estimates and Projections (2016-2027)
2.4.6 India Anti-PD-1 MAb Estimates and Projections (2016-2027)
3 Global Anti-PD-1 MAb Competition Landscape by Players
3.1 Global Top Anti-PD-1 MAb Players by Sales (2016-2021)
3.2 Global Top Anti-PD-1 MAb Players by Revenue (2016-2021)
3.3 Global Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2020)
3.4 Global Anti-PD-1 MAb Average Price by Company (2016-2021)
3.5 Manufacturers Anti-PD-1 MAb Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-PD-1 MAb Market Size by Type
4.1 Global Anti-PD-1 MAb Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-PD-1 MAb Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-PD-1 MAb Price by Type (2016-2021)
4.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-PD-1 MAb Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-PD-1 MAb Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-PD-1 MAb Price Forecast by Type (2022-2027)
5 Global Anti-PD-1 MAb Market Size by Application
5.1 Global Anti-PD-1 MAb Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-PD-1 MAb Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-PD-1 MAb Price by Application (2016-2021)
5.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-PD-1 MAb Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-PD-1 MAb Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-PD-1 MAb Price Forecast by Application (2022-2027)

6 North America Anti-PD-1 MAb Market Facts & Figures
6.1 North America Anti-PD-1 MAb Sales by Company
6.1.1 North America Anti-PD-1 MAb Sales by Company (2016-2021)
6.1.2 North America Anti-PD-1 MAb Revenue by Company (2016-2021)
6.2 North America Anti-PD-1 MAb Sales Breakdown by Type
6.2.1 North America Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
6.3 North America Anti-PD-1 MAb Sales Breakdown by Application
6.3.1 North America Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

7 Europe Anti-PD-1 MAb Market Facts & Figures
7.1 Europe Anti-PD-1 MAb Sales by Company
7.1.1 Europe Anti-PD-1 MAb Sales by Company (2016-2021)
7.1.2 Europe Anti-PD-1 MAb Revenue by Company (2016-2021)
7.2 Europe Anti-PD-1 MAb Sales Breakdown by Type
7.2.1 Europe Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-PD-1 MAb Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Anti-PD-1 MAb Market Facts & Figures
8.1 China Anti-PD-1 MAb Sales by Company
8.1.1 China Anti-PD-1 MAb Sales by Company (2016-2021)
8.1.2 China Anti-PD-1 MAb Revenue by Company (2016-2021)
8.2 China Anti-PD-1 MAb Sales Breakdown by Type
8.2.1 China Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
8.3 China Anti-PD-1 MAb Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Anti-PD-1 MAb Market Facts & Figures
9.1 Japan Anti-PD-1 MAb Sales by Company
9.1.1 Japan Anti-PD-1 MAb Sales by Company (2016-2021)
9.1.2 Japan Anti-PD-1 MAb Revenue by Company (2016-2021)
9.2 Japan Anti-PD-1 MAb Sales Breakdown by Type
9.2.1 Japan Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-PD-1 MAb Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-PD-1 MAb Market Facts & Figures
10.1 Southeast Asia Anti-PD-1 MAb Sales by Company
10.1.1 Southeast Asia Anti-PD-1 MAb Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-PD-1 MAb Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type
10.2.1 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Application
10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Anti-PD-1 MAb Market Facts & Figures
11.1 India Anti-PD-1 MAb Sales by Company
11.1.1 India Anti-PD-1 MAb Sales by Company (2016-2021)
11.1.2 India Anti-PD-1 MAb Revenue by Company (2016-2021)
11.2 India Anti-PD-1 MAb Sales Breakdown by Type
11.2.1 India Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
11.3 India Anti-PD-1 MAb Sales Breakdown by Application
11.3.1 India Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-PD-1 MAb Business
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Corporation Information
12.1.2 Bristol Myers Squibb Business Overview
12.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
12.1.5 Bristol Myers Squibb Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Anti-PD-1 MAb Products Offered
12.2.5 Merck Recent Development
12.3 Junshi Pharma
12.3.1 Junshi Pharma Corporation Information
12.3.2 Junshi Pharma Business Overview
12.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Junshi Pharma Anti-PD-1 MAb Products Offered
12.3.5 Junshi Pharma Recent Development
12.4 Innovent Biologics Inc
12.4.1 Innovent Biologics Inc Corporation Information
12.4.2 Innovent Biologics Inc Business Overview
12.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Innovent Biologics Inc Anti-PD-1 MAb Products Offered
12.4.5 Innovent Biologics Inc Recent Development
12.5 Hengrui Medicine
12.5.1 Hengrui Medicine Corporation Information
12.5.2 Hengrui Medicine Business Overview
12.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hengrui Medicine Anti-PD-1 MAb Products Offered
12.5.5 Hengrui Medicine Recent Development
12.6 Beijing Beigene
12.6.1 Beijing Beigene Corporation Information
12.6.2 Beijing Beigene Business Overview
12.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Beijing Beigene Anti-PD-1 MAb Products Offered
12.6.5 Beijing Beigene Recent Development
...

13 Anti-PD-1 MAb Manufacturing Cost Analysis
13.1 Anti-PD-1 MAb Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-PD-1 MAb
13.4 Anti-PD-1 MAb Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-PD-1 MAb Distributors List
14.3 Anti-PD-1 MAb Customers

15 Market Dynamics
15.1 Anti-PD-1 MAb Market Trends
15.2 Anti-PD-1 MAb Drivers
15.3 Anti-PD-1 MAb Market Challenges
15.4 Anti-PD-1 MAb Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Anti-PD-1 MAb Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-PD-1 MAb Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-PD-1 MAb Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-PD-1 MAb Sales (KG) by Region (2016-2021)
Table 5. Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
Table 6. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-PD-1 MAb Revenue Share by Region (2016-2021)
Table 8. Global Anti-PD-1 MAb Sales (KG) Forecast by Region (2022-2027)
Table 9. Global Anti-PD-1 MAb Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-PD-1 MAb Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-PD-1 MAb Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-PD-1 MAb Sales (KG) of Key Companies (2016-2021)
Table 13. Global Anti-PD-1 MAb Sales Share by Company (2016-2021)
Table 14. Global Anti-PD-1 MAb Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-PD-1 MAb Revenue Share by Company (2016-2021)
Table 16. Global Anti-PD-1 MAb by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 MAb as of 2020)
Table 17. Global Anti-PD-1 MAb Average Price (USD/KG) of Key Company (2016-2021)
Table 18. Manufacturers Anti-PD-1 MAb Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-PD-1 MAb Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-PD-1 MAb Sales (KG) by Type (2016-2021)
Table 22. Global Anti-PD-1 MAb Sales Share by Type (2016-2021)
Table 23. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-PD-1 MAb Price (USD/KG) by Type (2016-2021)
Table 25. Global Anti-PD-1 MAb Sales Share by Type (2022-2027)
Table 26. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-PD-1 MAb Revenue Share by Type (2022-2027)
Table 28. Global Anti-PD-1 MAb Price (USD/KG) by Type (2022-2027)
Table 29. Global Anti-PD-1 MAb Sales (KG) by Application (2016-2021)
Table 30. Global Anti-PD-1 MAb Sales Share by Application (2016-2021)
Table 31. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-PD-1 MAb Price (USD/KG) by Application (2016-2021)
Table 33. Global Anti-PD-1 MAb Sales (KG) by Application (2022-2027)
Table 34. Global Anti-PD-1 MAb Sales Share by Application (2022-2027)
Table 35. Global Anti-PD-1 MAb Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-PD-1 MAb Revenue Share by Application (2022-2027)
Table 37. Global Anti-PD-1 MAb Price (USD/KG) by Application (2022-2027)
Table 38. North America Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 39. North America Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 40. North America Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 43. North America Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 44. North America Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 45. North America Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 46. North America Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 47. North America Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 48. North America Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 49. North America Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 51. Europe Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 55. Europe Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 57. Europe Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 59. Europe Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 61. Europe Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 62. China Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 63. China Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 64. China Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 66. China Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 67. China Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 68. China Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 69. China Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 70. China Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 71. China Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 72. China Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 73. China Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 75. Japan Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 79. Japan Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 81. Japan Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 83. Japan Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 85. Japan Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 87. Southeast Asia Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 91. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 93. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 95. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 97. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 98. India Anti-PD-1 MAb Sales (KG) by Company (2016-2021)
Table 99. India Anti-PD-1 MAb Sales Market Share by Company (2016-2021)
Table 100. India Anti-PD-1 MAb Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-PD-1 MAb Revenue Market Share by Company (2016-2021)
Table 102. India Anti-PD-1 MAb Sales by Type (2016-2021) & (KG)
Table 103. India Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
Table 104. India Anti-PD-1 MAb Sales by Type (2022-2027) & (KG)
Table 105. India Anti-PD-1 MAb Sales Market Share by Type (2022-2027)
Table 106. India Anti-PD-1 MAb Sales by Application (2016-2021) & (KG)
Table 107. India Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
Table 108. India Anti-PD-1 MAb Sales by Application (2022-2027) & (KG)
Table 109. India Anti-PD-1 MAb Sales Market Share by Application (2022-2027)
Table 110. Bristol Myers Squibb Corporation Information
Table 111. Bristol Myers Squibb Description and Business Overview
Table 112. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 113. Bristol Myers Squibb Anti-PD-1 MAb Product
Table 114. Bristol Myers Squibb Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 118. Merck Anti-PD-1 MAb Product
Table 119. Merck Recent Development
Table 120. Junshi Pharma Corporation Information
Table 121. Junshi Pharma Description and Business Overview
Table 122. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 123. Junshi Pharma Anti-PD-1 MAb Product
Table 124. Junshi Pharma Recent Development
Table 125. Innovent Biologics Inc Corporation Information
Table 126. Innovent Biologics Inc Description and Business Overview
Table 127. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 128. Innovent Biologics Inc Anti-PD-1 MAb Product
Table 129. Innovent Biologics Inc Recent Development
Table 130. Hengrui Medicine Corporation Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 133. Hengrui Medicine Anti-PD-1 MAb Product
Table 134. Hengrui Medicine Recent Development
Table 135. Beijing Beigene Corporation Information
Table 136. Beijing Beigene Description and Business Overview
Table 137. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2016-2021)
Table 138. Beijing Beigene Anti-PD-1 MAb Product
Table 139. Beijing Beigene Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Anti-PD-1 MAb Distributors List
Table 143. Anti-PD-1 MAb Customers List
Table 144. Anti-PD-1 MAb Market Trends
Table 145. Anti-PD-1 MAb Market Drivers
Table 146. Anti-PD-1 MAb Market Challenges
Table 147. Anti-PD-1 MAb Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-PD-1 MAb Product Picture
Figure 2. Global Anti-PD-1 MAb Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-PD-1 MAb Sales Market Share by Application in 2021 & 2027
Figure 6. Melanoma Patients Examples
Figure 7. Lung Cancer Patients Examples
Figure 8. Lymphoma Patients Examples
Figure 9. Other Examples
Figure 10. Global Anti-PD-1 MAb Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anti-PD-1 MAb Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Anti-PD-1 MAb Sales (KG) Growth Rate (2016-2027)
Figure 13. Global Anti-PD-1 MAb Price Trends Growth Rate (2016-2027) (USD/KG)
Figure 14. Global Anti-PD-1 MAb Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Anti-PD-1 MAb Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Anti-PD-1 MAb Sales (KG) Growth Rate (2016-2027)
Figure 18. Europe Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Anti-PD-1 MAb Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Anti-PD-1 MAb Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Anti-PD-1 MAb Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Anti-PD-1 MAb Players Market Share by Revenue in Anti-PD-1 MAb: 2016 & 2020
Figure 29. Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Anti-PD-1 MAb Revenue Share by Type (2016-2021)
Figure 31. Global Anti-PD-1 MAb Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Anti-PD-1 MAb Revenue Share by Application (2016-2021)
Figure 33. Global Anti-PD-1 MAb Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 35. North America Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 36. Europe Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 37. Europe Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 38. China Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 39. China Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 40. Japan Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 41. Japan Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 42. Southeast Asia Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 43. Southeast Asia Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 44. India Anti-PD-1 MAb Sales Market Share by Type in 2020
Figure 45. India Anti-PD-1 MAb Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Anti-PD-1 MAb
Figure 48. Manufacturing Process Analysis of Anti-PD-1 MAb
Figure 49. Anti-PD-1 MAb Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.